€46.49
0.85% yesterday
Xetra, Jun 20, 05:35 pm CET
ISIN
DE0005785802
Symbol
FME
Index

Fresenius Medical Care Stock price

€46.49
-7.17 13.36% 1M
+2.61 5.95% 6M
+2.33 5.28% YTD
+9.99 27.37% 1Y
-29.45 38.78% 5Y
-29.86 39.11% 10Y
+23.39 101.26% 20Y
Xetra, Closing price Fri, Jun 20 2025
+0.39 0.85%
ISIN
DE0005785802
Symbol
FME
Index
Sector

Key metrics

Market capitalization €13.53b
Enterprise Value €22.86b
P/E (TTM) P/E ratio 22.03
EV/FCF (TTM) EV/FCF 13.60
EV/Sales (TTM) EV/Sales 1.17
P/S ratio (TTM) P/S ratio 0.69
P/B ratio (TTM) P/B ratio 0.95
Dividend yield 3.10%
Last dividend (FY24) €1.44
Revenue growth (TTM) Revenue growth 0.10%
Revenue (TTM) Revenue €19.49b
EBIT (operating result TTM) EBIT €1.40b
Free Cash Flow (TTM) Free Cash Flow €1.68b
Cash position €1.49b
EPS (TTM) EPS €2.11
P/E forward 14.25
P/S forward 0.69
EV/Sales forward 1.16
Show more

Create a Free Account to create an Fresenius Medical Care alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Fresenius Medical Care Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Fresenius Medical Care forecast:

7x Buy
32%
10x Hold
45%
5x Sell
23%

Analyst Opinions

22 Analysts have issued a Fresenius Medical Care forecast:

Buy
32%
Hold
45%
Sell
23%

Financial data from Fresenius Medical Care

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
19,493 19,493
0% 0%
100%
- Direct Costs 14,726 14,726
1% 1%
76%
4,767 4,767
4% 4%
24%
- Selling and Administrative Expenses 3,118 3,118
2% 2%
16%
- Research and Development Expense 179 179
19% 19%
1%
3,023 3,023
3% 3%
16%
- Depreciation and Amortization 1,624 1,624
11% 11%
8%
EBIT (Operating Income) EBIT 1,398 1,398
9% 9%
7%
Net Profit 618 618
28% 28%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Fresenius Medical Care directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fresenius Medical Care Stock News

AD HOC NEWS
4 days ago
Das US-Analysehaus Bernstein Research hat das Kursziel für FMC DE0005785802 nach dem diesjährigen Kapitalmarkttag von 50,00 auf 54,50 Euro angehoben, aber die Einstufung auf "Market-Perform" belassen.
AD HOC NEWS
5 days ago
Das Analysehaus Jefferies hat FMC DE0005785802 mit einem Kursziel von 40 Euro auf "Underperform" belassen.
More Fresenius Medical Care News

Company Profile

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Head office Germany
CEO Helen Giza
Employees 111,513
Founded 1996
Website www.freseniusmedicalcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today